» Articles » PMID: 34336597

Lack of N2-gene Amplification on the Cepheid Xpert Xpress SARS-CoV-2 Assay and Potential Novel Causative Mutations: A Case Series from Auckland, New Zealand

Overview
Journal IDCases
Date 2021 Aug 2
PMID 34336597
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We describe three cases with viral strains that demonstrate impaired N2-gene detection on the Cepheid Xpert Xpress SARS-CoV-2 assay, with two previously undescribed single nucleotide polymorphisms (SNPs): C29197T and G29227T. We propose that these SNPs are likely responsible since they are in close proximity to the previously described C29200T/C29200A SNPs, already shown to abolish N2-gene detection by the Xpert assay. Whether these SNPs abolish N2-gene detection by the Xpert assay individually or only in combination requires more work to elucidate.

Citing Articles

Partial N-gene target failure in the Seegene Allplex SARS-CoV-2 Master Assay as a proxy of SARS-CoV-2 BA.2.86.

Valli M, Schiavone M, Rueca M, Berno G, Spezia P, Gruber C Microbiol Spectr. 2024; 12(6):e0017924.

PMID: 38647335 PMC: 11237703. DOI: 10.1128/spectrum.00179-24.


A mutation responsible for impaired detection by the Xpert SARS-CoV-2 assay independently emerged in different lineages during the SARS-CoV-2 pandemic.

Penas-Utrilla D, Sanz A, Catalan P, Veintimilla C, Alcala L, Alonso R BMC Microbiol. 2023; 23(1):190.

PMID: 37460980 PMC: 10351113. DOI: 10.1186/s12866-023-02924-8.


Cycle Threshold (Ct) Values of SARS-CoV-2 Detected with the GeneXpert System and a Mutation Associated with Different Target Gene Failure.

Yamashita K, Taniguchi T, Niizeki N, Nagao Y, Suzuki A, Toguchi A Curr Issues Mol Biol. 2023; 45(5):4124-4134.

PMID: 37232731 PMC: 10217001. DOI: 10.3390/cimb45050262.


Impact of G29179T mutation on two commercial PCR assays for SARS-CoV-2 detection.

Kami W, Kinjo T, Hashioka H, Arakaki W, Uechi K, Takahashi A J Virol Methods. 2023; 314:114692.

PMID: 36796678 PMC: 9930255. DOI: 10.1016/j.jviromet.2023.114692.


Infection clusters can elevate risk of diagnostic target failure for detection of SARS-CoV-2.

Lopez D, Roberts J, Bourgeois M, Kootstra J, Minnick S, Black A PLoS One. 2022; 17(2):e0264008.

PMID: 35171960 PMC: 8849547. DOI: 10.1371/journal.pone.0264008.


References
1.
Corman V, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu D . Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3). PMC: 6988269. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045. View

2.
Wang R, Hozumi Y, Yin C, Wei G . Mutations on COVID-19 diagnostic targets. Genomics. 2020; 112(6):5204-5213. PMC: 7502284. DOI: 10.1016/j.ygeno.2020.09.028. View

3.
Loeffelholz M, Alland D, Butler-Wu S, Pandey U, Perno C, Nava A . Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test. J Clin Microbiol. 2020; 58(8). PMC: 7383535. DOI: 10.1128/JCM.00926-20. View

4.
Ziegler K, Steininger P, Ziegler R, Steinmann J, Korn K, Ensser A . SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene. Euro Surveill. 2020; 25(39). PMC: 7531073. DOI: 10.2807/1560-7917.ES.2020.25.39.2001650. View

5.
Mostafa H, Carroll K, Hicken R, Berry G, Manji R, Smith E . Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test. J Clin Microbiol. 2020; 59(3). PMC: 8106732. DOI: 10.1128/JCM.02955-20. View